NOVT (Novanta) Common Stock : $423.9 Mil (As of Sep. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Novanta Common Stock?

Novanta's quarterly common stock stayed the same from Mar. 2024 ($423.9 Mil) to Jun. 2024 ($423.9 Mil) and stayed the same from Jun. 2024 ($423.9 Mil) to Sep. 2024 ($423.9 Mil).

Novanta's annual common stock stayed the same from Dec. 2021 ($423.9 Mil) to Dec. 2022 ($423.9 Mil) and stayed the same from Dec. 2022 ($423.9 Mil) to Dec. 2023 ($423.9 Mil).

Novanta Common Stock Historical Data

The historical data trend for Novanta's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novanta Common Stock Chart

Novanta Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

423.86

Novanta Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Common Stock	Get a 7-Day Free Trial															423.86	423.86	423.86	423.86	423.86

Novanta Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Novanta Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Novanta Inc (NAS:NOVT) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

0VAG:UK 1GSN:Germany 1GSN:Germany

Address

125 Middlesex Turnpike, Bedford, MA, USA, 01730

Website

https://www.novanta.com

Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

Executives

Robert Buckley	officer: Chief Financial Officer	C/O GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730-1409
Matthijs Glastra	officer: Group President,Laser Products	C/O GSI GROUP CORPORATION, 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730
Thomas N Secor	director	GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730
Brian S Young	officer: Executive VP, Human Resources	C/O 25 CORPORATE DRIVE, BURLINGTON MA 01803
Barbara B. Hulit	director	C/O FORTIVE CORPORATION, 6920 SEAWAY BLVD, EVERETT WA 98203
Michele Davis Welsh	officer: General Counsel	C/O NOVANTA INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730
Solomon Darlene J. S.	director	6070 PARKLAND BLVD., MAYFIELD HTS. OH 44124
Peter L Chang	officer: Vice President-Corp Controller	C/O GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730
Frank Anders Wilson	director	C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Katherine Ann Owen	director	2825 AIRVIEW BLVD., KALAMAZOO MI 49002
Maxine Lum Mauricio	director	301 MERRITT SEVEN CORPORATE PARK, 6TH FL, C/O EMCOR GROUP INC., NORWALK CT 06851
Stephen W Bershad	director	66 ARROYO HONDO TRAIL, SANTA FE NM 87508
Deborah Disanzo	director	7601 PENN AVENUE SOUTH, RICHFIELD MN 55423
Lonny J Carpenter	director	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Brian Douglas King	director	C/O NOVANTA INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730